aggregates in lyophilized albumin preparations, and (d) sample-to-sample interactions during electrophoresis. Recently, we have succeeded in adapting these EIA kits for use with a Technicon AutoAnalyzer II with a microffiter FM 65 (Fuji Photo Film Co., Tokyo 106), and now can measure the serum AED semi-automatically. In the manual (kit) method, the competitive immuno-reaction mixture between AED in samples and E-AED against anti-AED immunoglobulin coupled to carrier bacterial cell walls in test tubes with tight rubber capsis centrifuged upside down. To the free E-AED recovered in the supernate after the tubes are set upright on the test tube rack, one adds substrate for measurement of the enzyme activity, which has a stoichiometric relationship with AED concentrations in the samples (Figure 1) . In semi-automation of the EIA, the mixture containing the competitive immuno-reaction between AED in samples and E-AED against the anti-AED is aspirated into the pumping tube (Figure 2) , and the free E-AED, separated from the bound E-AED by a membrane (B/F separation),
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Materials and Methods

Reagents
We used the following reagents from kssu'r kits for phenytoin, phenobarbital, primidone, carbamazepine, and valproic acid. The kits, each of which suffices for 50 assays, 
Procedures
Manual EJA method.
We followed the kit instructions without modification, which are, in brief: Pipet 100 iL of standard AED solutions or of sample diluted 10-fold with distilled water into glass test tubes, mix with 500 L of E-AED solution, then add 200 L of the insolubilized anti-
, then centrifuge the tubes upside-down (1000-1500 x g, 10 mm). The supernate contains the free E-AED; the insolubilized antibody with the bound E-AED sticks to the caps. After adding substrate to the supernate to react with the enzyme, measure the absorbance at 410 nm against water and determine the AED concentrations in the samples by reference to the standard calibration curve.
Semi-automated
EIA method. Prepare the reaction mixture as described above, up to the incubation step. Distribute each 800-L mixture into three 250-tL portions for the sampler cups. That is, both the three standard Solutions and the samples are run in triplicate cups. Incubate at 37 #{176}C for 2 h. During the incubation, precondition the flow path by pumping the wash solution into the tubes for the buffer, the substrate solution, and the reaction mixture until a constant throughput of bubbles can be established. Start feeding the buffer solution first; 5 mm later, start the substrate solution; after another 5 mm, start the wash solution in 3 cups (blanks), the standard solutions in 3 x 6 cups, and the samples in 3 x n cups, successively.
Set the recorder pen to 30 on the chart scale when the first response peak of standard 0 appears on the recorder chart, and allow the following response peaks to be successively recorded on the chart. Read the peak height of the chart response of both standard AED and samples. Generate the standard calibration curve manually or by a spline-functionprogrammed computer for calculation of AED concentrations in the samples.
Other methods. For comparison, we also measured AED in serum by gas-liquid chromatography (6) and "high-pressure" liquid chromatography (7).
Resuits
In this semi-automated EIA system, we found no significant differences among results from the five kinds of analytes measured with the AED kits. Some representative data follow.
Standard calibration
curve. Figure 3 shows typical standard calibration curves obtained by using the kits' reagents with the semi-automated EIA system. The CV of the absorbance (chart scale) values for six concentrations of the AED standard was less than 3% (mean of triplicate determinations), well tolerable for the practical monitoring of AED in
serum.
Carryover.
In general, carryover in this semi-automated EIA system was negligible, as shown in Figure 4A , but in rare cases was as seen in Figure 48 . The carryover could be easily detected and eliminated by selecting the heightof the most reliable of the triple response peaks, usually the third of the three. The maximum carryover from, e.g., 20 to 3 mg/ L was 5.8%, but became <1% by the time of the third response peak (Figure 48, k) .
Reproducibility.
To assess within-run variation, we successively measured three serum samples (containing 8, 19, and 45 mg of phenobarbital per liter by the semi-automated EIA) 10 times; the respectiveCVs were 2.3, 2i, and 3.4%. The day-to-day CV, on assaying one serum sample contain- and 0.05 mL/min, to subject them to the competitive immuno-reaction (5 nun at 37#{176}C), followed by dialysis of the free E-AED for the enzyme reaction with the substrate as discussed for the present method. This fully automated EIA produced good results but had the following two drawbacks. First, the useful life of the membrane was short, mainly because the cell walls tagged with anti-AED blocked the pores of the membrane, affecting assay reproducibility. Second, excess E-AED and insolubilized anti-AED were needed during preconditioning to attain the continuous flow. To overcome these two drawbacks, we eliminated the PM continuous-flow process of the competitive immuno-reaction between E-AED and serum AED against anti-AED, and adopted the present semi-automated EIA. With this semiautomated EIA system, we could not only obtain reproducible results and prolong the usefulness of the membrane, but also decrease the amount of expensive reagents needed for _______________ preconditioning. 
Discussion
Before establishing the present semi-automated EIA, we extensivelystudied a fullyautomated EIA for measurement of serum AED, in which E-AED, serum AED, and anti-AED were pumped into a coil at respective flow rates of 0.32, 0.10
In conclusion, the semi-automated EIA has the following advantages over the manual EIA.
#{149} The process for separating bound and free analyte and the enzyme reaction and the colorimetry are all fully automated and give reproducible results.
#{149} By changing only the competitive immuno-reaction mixture, different drugs can be measured successively many times without changing the membrane.
'The smaller sample volume means that triplicate assays (3 x 250 p.L of the reaction mixture) require only as much reagent as was required for one assay in the manual EIA (800 tL of the reaction mixture).
#{149}
Other MARKIT series kits for gentamicin, tobramycin, amikacin, and theophyllime can be applicable to this system.
